Form 8-K Filing - Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc. is announcing the postponement of its special meeting of stockholders from September 3, 2026, to September 9, 2026. The company has decided to postpone the meeting to allow more time for soliciting proxies, for stockholders to consider the proposals and vote, and to allow stockholders additional time to review an amendment to the terms of Milestone Events. Proxies submitted before the original meeting date will remain valid unless revoked. The company is also providing additional time for stockholders to consider an amendment to the terms of the Milestone Events described in a previous filing.